Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: Mirum Pharmaceuticals Inc., 3 years.
Mirum Pharmaceuticals Inc.
Director
Spruce Biosciences Inc.
Director · Executive Chairman
OnKure Therapeutics Inc.
Director · Executive Chairman
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 19, 2025 | Mirum Pharmaceuticals Inc. | Option exercise | +50,000 | $2.94 | $147,000 |
| Dec 19, 2025 | Mirum Pharmaceuticals Inc. | Open-market sale | −50,000 | $78.00 | $3,900,000 |
| Dec 1, 2025 | Mirum Pharmaceuticals Inc. | Option exercise | +50,000 | $2.94 | $147,000 |
| Dec 1, 2025 | Mirum Pharmaceuticals Inc. | Open-market sale | −50,000 | $74.00 | $3,700,000 |
| Nov 21, 2025 | Mirum Pharmaceuticals Inc. | Option exercise | +50,000 | $2.94 | $147,000 |
| Nov 21, 2025 | Mirum Pharmaceuticals Inc. | Open-market sale | −50,000 | $70.00 | $3,500,000 |
| Sep 27, 2024 | Mirum Pharmaceuticals Inc. | Gift | −102,788 | — | — |
| Sep 14, 2023 | Mirum Pharmaceuticals Inc. | Option exercise | +14,216 | $2.94 | $41,795 |
| Sep 14, 2023 | Mirum Pharmaceuticals Inc. | Open-market sale | −14,216 | $32.00 | $454,912 |
| Sep 13, 2023 | Mirum Pharmaceuticals Inc. | Option exercise | +392 | $2.94 | $1,152 |
| Sep 13, 2023 | Mirum Pharmaceuticals Inc. | Open-market sale | −392 | $32.00 | $12,544 |
| Jul 26, 2023 | OnKure Therapeutics Inc. | Gift | −50,000 | — | — |
| Jun 8, 2023 | Mirum Pharmaceuticals Inc. | Option exercise | +14,608 | $2.94 | $42,948 |
| Jun 8, 2023 | Mirum Pharmaceuticals Inc. | Open-market sale | −14,608 | $29.00 | $423,632 |
| May 3, 2023 | Mirum Pharmaceuticals Inc. | Option exercise | +14,608 | $2.94 | $42,948 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.